Shalini L. Kulasingam
Affiliations: | Epidemiology | University of Minnesota, Twin Cities, Minneapolis, MN |
Area:
Public Health, Public Health Education, Oncology, Health Care ManagementGoogle:
"Shalini Kulasingam"Cross-listing: Epi Tree
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Xiong S, Ghebre R, Kulasingam S, et al. (2023) Exploring factors associated with preferences for human papillomavirus (HPV) self-sampling among racially- and ethnically-diverse women in Minnesota: A cross-sectional study. Preventive Medicine Reports. 34: 102243 |
Zhao R, Sekar P, Bennis SL, et al. (2023) A systematic review of the association between smoking exposure and HPV-related cervical cell abnormality among women living with HIV: Implications for prevention strategies. Preventive Medicine. 170: 107494 |
Xiong S, Lazovich A, Hassan F, et al. (2022) Health care personnel's perspectives on human papillomavirus (HPV) self-sampling for cervical cancer screening: a pre-implementation, qualitative study. Implementation Science Communications. 3: 130 |
Teoh D, Nam G, Aase DA, et al. (2022) Test Performance of Cervical Cytology Among Adults With vs Without Human Papillomavirus Vaccination. Jama Network Open. 5: e2214020 |
Zhao R, Liang S, Teoh D, et al. (2022) A comprehensive cross-sectional survey to identify barriers and facilitators of cervical cancer screening in women with HIV in Guangxi, China. Infectious Agents and Cancer. 17: 12 |
Yared N, Malone M, Welo E, et al. (2021) Challenges related to human papillomavirus (HPV) vaccine uptake in Minnesota: clinician and stakeholder perspectives. Cancer Causes & Control : Ccc |
Holt HK, Kulasingam S, Sanstead EC, et al. (2020) Discussing Cervical Cancer Screening Options: Outcomes to Guide Conversations Between Patients and Providers. Mdm Policy & Practice. 5: 2381468320952409 |
Simms KT, Yuill S, Killen J, et al. (2020) Historical and projected hysterectomy rates in the USA: Implications for future observed cervical cancer rates and evaluating prevention interventions. Gynecologic Oncology |
de Kok IMCM, Burger EA, Naber SK, et al. (2020) The Impact of Different Screening Model Structures on Cervical Cancer Incidence and Mortality Predictions: The Maximum Clinical Incidence Reduction (MCLIR) Methodology. Medical Decision Making : An International Journal of the Society For Medical Decision Making. 272989X20924007 |
Silverberg MJ, Leyden WA, Lam JO, et al. (2020) Effectiveness of 'catch-up' human papillomavirus vaccination to prevent cervical neoplasia in immunosuppressed and non-immunosuppressed women. Vaccine |